Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...
How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...
Forbes contributors publish independent expert analyses and insights. Vibe coding, using AI to build prototypes, can be a trap for founders. While empowering, it risks undermining specialist teams, ...
Security researchers have discovered 10 new indirect prompt injection (IPI) payloads targeting AI agents with malicious instructions designed to achieve financial fraud, data destruction, API key ...
Whether you're a beginning coder or a seasoned developer, we've tested hundreds of laptops to help you find the performance you need to power through your next project deadline. From the laptops on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results